Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Noble

Showing results (551-560 of 568) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|July 2, 2021
An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing KinaseIslam Al-Khawaldeh, Mohammed J Al Yasiri, Gregory G Aldred, et al.
Evolutionary Applications|January 26, 2023
Towards evolutionary predictions: Current promises and challengesMeike T Wortel, Deepa Agashe, Susan F Bailey, et al.
NPJ Dementia|February 19, 2026
15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 24, 2022
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJonathan Vöglein, Nicolai Franzmeier, John C Morris, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Journal of Medicinal Chemistry|March 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein InteractionGianni Chessari, Ian R Hardcastle, Jong Sook Ahn, et al.
Neurology|August 17, 2021
Contemporary Neuroscience Core Curriculum for Medical SchoolsDouglas J Gelb, Jeff Kraakevik, Joseph E Safdieh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Pageof 57

Showing results (551-560 of 568) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|July 2, 2021
An Alkynylpyrimidine-Based Covalent Inhibitor That Targets a Unique Cysteine in NF-κB-Inducing KinaseIslam Al-Khawaldeh, Mohammed J Al Yasiri, Gregory G Aldred, et al.
Evolutionary Applications|January 26, 2023
Towards evolutionary predictions: Current promises and challengesMeike T Wortel, Deepa Agashe, Susan F Bailey, et al.
NPJ Dementia|February 19, 2026
15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 24, 2022
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer diseaseJonathan Vöglein, Nicolai Franzmeier, John C Morris, et al.
The Lancet. Neurology|January 22, 2022
Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational studyJasmeer P Chhatwal, Stephanie A Schultz, Eric McDade, et al.
Medrxiv : the Preprint Server for Health Sciences|August 16, 2024
15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIANAlisha J Daniels, Eric McDade, Jorge J Llibre-Guerra, et al.
Journal of Medicinal Chemistry|March 24, 2021
Structure-Based Design of Potent and Orally Active Isoindolinone Inhibitors of MDM2-p53 Protein-Protein InteractionGianni Chessari, Ian R Hardcastle, Jong Sook Ahn, et al.
Neurology|August 17, 2021
Contemporary Neuroscience Core Curriculum for Medical SchoolsDouglas J Gelb, Jeff Kraakevik, Joseph E Safdieh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2022
Biomarker clustering in autosomal dominant Alzheimer's diseasePatrick H Luckett, Charlie Chen, Brian A Gordon, et al.
Nature Medicine|August 7, 2023
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's diseaseErik C B Johnson, Shijia Bian, Rafi U Haque, et al.
Pageof 57